Oncternal Therapeutics Inc (ONCT)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
James B. Breitmeyer
Employees:
30
12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
858 434-1113

Oncternal Therapeutics, Inc. focuses on the development of oncology therapies for cancers with critical unmet medical needs. Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1)

Data derived from most recent annual or quarterly report
Market Cap 25.416 Million Shares Outstanding58.969 Million Avg 30-day Volume 160.623 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.21
Price to Revenue26.8425 Debt to Equity0.0 EBITDA-45.334 Million
Price to Book Value0.4781 Operating Margin-6675.720800000001 Enterprise Value-22.616 Million
Current Ratio8.248 EPS Growth0.111 Quick Ratio7.823
1 Yr BETA 1.0445 52-week High/Low 1.33 / 0.26 Profit Margin-6330.0455
Operating Cash Flow Growth-1.2501 Free Cash Flow to Firm (FCFF) TTM -29.57 Million Free Cash Flow to Equity (FCFE) TTM-30.795 Million
Altman Z-Score-6.7095
View SEC Filings from ONCT instead.

View recent insider trading info

Oncternal Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ONCT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ONCT

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-10-04 by LEAVITT CHASE C.
  • 4: filed on 2023-10-04 by YAZJI SALIM
  • 4: filed on 2023-10-04 by VINCENT RICHARD G
  • 4: filed on 2023-10-04 by KRISHNAN RAJESH
  • 4: filed on 2023-07-05 by LEAVITT CHASE C.
  • 4: filed on 2023-07-05 by VINCENT RICHARD G
  • 4: filed on 2023-07-05 by YAZJI SALIM
  • 4: filed on 2023-07-05 by KRISHNAN RAJESH
  • 4: filed on 2023-06-30 by THEUER CHARLES
  • 4: filed on 2023-06-30 by CARTER MICHAEL G

    • Events (8k)

  • 8-K: filed on 2023-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-06:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K/A: filed on 2023-09-14:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-29:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-06-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-04-06:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-04-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
  • 8-K/A: filed on 2023-03-17:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-03-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    BREITMEYER JAMES B CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2023-10-02 5

    VINCENT RICHARD G CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-10-02 5

    LEAVITT CHASE C. GENERAL COUNSEL/SECRETARY

    • Officer
    		 0 2023-10-02 5

    YAZJI SALIM CHIEF MEDICAL OFFICER

    • Officer
    		 0 2023-10-02 5

    KRISHNAN RAJESH CHIEF TECHNICAL OFFICER

    • Officer
    		 0 2023-10-02 4

    HALE DAVID F

    • Director
    		 0 2023-06-28 1

    KISNER DANIEL L

    • Director
    		 0 2023-06-28 1

    LARUE WILLIAM R

    • Director
    		 0 2023-06-28 1

    CARTER MICHAEL G

    • Director
    		 0 2023-06-28 1

    MAZANET ROSEMARY

    • Director
    		 0 2023-06-28 1

    THEUER CHARLES

    • Director
    		 0 2023-06-28 1

    WILLS ROBERT JAMES

    • Director
    		 0 2023-06-28 1

    NAKANISHI XIN

    • Director
    		 0 2023-06-28 1

    DESIMONE JILL

    • Director
    		 0 2023-06-28 3

    KAUFMANN GUNNAR F. CHIEF SCIENTIFIC OFFICER

    • Officer
    		 94,726 2023-06-12 3

    CHEN JINZHU PHD

    • Director
    		 25,000 2022-06-16 0

    BILINSKY IGOR CHIEF BUSINESS OFFICER

    • Officer
    		 0 2021-02-11 0

    AKER HAZEL M LEGAL COUNSEL

    • Officer
    		 51,271 2020-07-21 0

    SHANGHAI PHARMACEUTICAL (USA) INC.

    SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.

    • 10% Owner
    		 3,544,431 2020-07-21 0

    SHANGHAI PHARMACEUTICALS (HK) INVESTMENT LTD

    • 10% Owner
    		 1,049,317 2020-07-21 0

    CHO MAN

    • Director
    		 0 2020-06-11 0

    HSU FRANK J. CHIEF MEDICAL OFFICER

    • Officer
    		 0 2020-03-17 0

    LIU YANJUN

    • Director
    		 0 2019-09-12 0

    SHANGHAI PHARMACEUTICAL (USA) INC.

    • 10% Owner
    		 0 2019-06-07 0

    HYDE JOSEPH R III

    • Director
    • 10% Owner
    		 6,877,615 2019-01-02 0

    NEIL GARRY ARTHUR

    • Director
    		 36,759 2019-01-02 0

    ROBINSON KENNETH S

    • Director
    		 44,105 2018-10-01 0

    YOUNG DIANE C. VP, CHIEF MEDICAL OFFICER

    • Officer
    		 45,936 2018-07-13 0

    DOGGRELL HENRY PATTON VP, CHIEF LEGAL OFFICER

    • Officer
    		 48,175 2018-06-20 0

    SHACKELFORD JASON T PRIN FIN. & ACCT. OFFICER

    • Officer
    		 19,548 2018-06-20 0

    GLASS J KENNETH

    • Director
    		 0 2018-05-10 0

    HANOVER MARC STEVEN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 172,049 2018-01-05 0

    PYRAMID PEAK FOUNDATION

    • 10% Owner
    		 4,729,417 2017-09-29 0

    FURR BARRY J. A.

    • Director
    		 48,469 2015-01-02 0

    DALTON JAMES T VP, CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2014-06-06 0

    SCHULER JACK W

    • 10% Owner
    		 6,165,261 2014-03-19 0

    STEINER MITCHELL SHUSTER CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 4,673,367 2014-01-29 0

    MOSTELLER MARK EDWARD VICE PRESIDENT, CFO

    • Officer
    		 7,282 2013-07-08 0

    SEAR TIMOTHY R G

    • Director
    		 195,668 2013-01-01 0

    MORTON RONALD A JR VP, CHIEF MEDICAL OFFICER

    • Officer
    		 0 2012-01-01 0

    PONTIUS JOHN HOFMANN

    • Director
    		 157,339 2011-07-01 0

    DEENER GREGORY A VICE PRESIDENT

    • Officer
    		 0 2011-01-01 0

    KARR ROBERT W

    • Director
    		 0 2010-04-30 0

    BARNETTE K GARY VICE PRESIDENT

    • Officer
    		 No longer subject to file 2008-07-30 0

    HESSELBERG JEFFREY G VICE PRESIDENT, REGULATORY

    • Officer
    		 No longer subject to file 2008-07-30 0

    WEST CHRISTOPHER K VICE PRESIDENT - SALES

    • Officer
    		 No longer subject to file 2008-07-30 0

    BROWN MICHAEL DENNY VICE PRESIDENT

    • Officer
    		 No longer subject to file 2008-07-30 0

    DODSON SHONTELLE VICE PRESIDENT

    • Officer
    		 No longer subject to file 2008-07-30 0

    RODRIGUEZ DOMINGO VICE PRESIDENT

    • Officer
    		 No longer subject to file 2008-07-30 0

    CLARKSON ANDREW M

    • Director
    		 No longer subject to file 2008-06-30 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 22:15:04 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 21:45:04 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 21:15:04 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 20:45:04 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 20:15:07 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 19:45:04 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 19:15:03 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 18:45:03 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 18:15:04 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 17:45:03 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 17:15:03 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 16:45:05 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 16:15:04 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 15:45:04 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 15:15:04 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 14:45:04 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 14:15:03 UTC -2.776 8.096 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 13:45:03 UTC 0.4158 4.9042 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 13:15:04 UTC 0.4158 4.9042 1600000
    ONCTERNAL THERAPEUTICS INC ONCT 2023-12-08 12:45:05 UTC 0.4158 4.9042 1600000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments